<div id="subtitle">PharmaGap ships lead cancer drug compound to U.S. for testing</div><div><p>Shares of Ottawa-based biotech PharmaGap (TSX:V.GAP, Stock Forum) climbed 26.7% to 19 cents Friday, after the company announced that it has shipped its lead cancer drug compound, PhG-alpha-1, to the National ...

<div id="subtitle">PharmaGap lead drug compound to be tested at U.S. National Cancer Institute</div><div><p>Shares of Ottawa-based PharmaGap (TSX: V.GAP, Stock Forum) surged 50% to 21 cents Thursday, after the biotechnology company announced that its lead drug compound has been accepted for testing at the ...